A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice

BACKGROUND: Fabry disease (FD) is a genetic disorder caused by a deficiency in the enzyme alpha-galactosidase A, leading to an accumulation of glycosphingolipids in tissues across the body. Cardiac disease is the leading cause of morbidity and mortality. Advanced disease, characterised by extensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijapurapu, Ravi, Kozor, Rebecca, Hughes, Derralynn A., Woolfson, Peter, Jovanovic, Ana, Deegan, Patrick, Rusk, Rosemary, Figtree, Gemma A., Tchan, Michel, Whalley, David, Kotecha, Dipak, Leyva, Francisco, Moon, James, Geberhiwot, Tarekegn, Steeds, Richard P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544923/
https://www.ncbi.nlm.nih.gov/pubmed/31151481
http://dx.doi.org/10.1186/s13063-019-3425-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544923/
https://www.ncbi.nlm.nih.gov/pubmed/31151481
http://dx.doi.org/10.1186/s13063-019-3425-1

Ejemplares similares